{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T08:20:43Z","timestamp":1774686043854,"version":"3.50.1"},"reference-count":39,"publisher":"American Society for Microbiology","issue":"7","license":[{"start":{"date-parts":[[2000,7,1]],"date-time":"2000-07-01T00:00:00Z","timestamp":962409600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2000,7]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>Imiquimod (IQ) has been successfully used in treatment of genital warts. In clinical settings, patients responded well but wart reduction rates varied. Our aim was to find a correlation between clinical responses and pretreatment (constitutive) levels of genes that might be involved in the molecular action of IQ. Since IQ is a cytokine inducer, we analyzed levels of expression of genes of the JAK\/STAT signaling pathway and their inhibitors as well as interferon response factors (IRFs) in pretreatment biopsy specimens from complete responders (99 to 100% wart reduction rate) versus incomplete responders (75 to 92% wart reduction rate) by reverse transcription-PCR. We found that mRNA levels of signal transducer and activator of transcription 1 (STAT1) and IRF1 were higher in complete responders than in incomplete responders. Incomplete responders expressed larger amounts of STAT3, IRF2, and protein inhibitor of activated STAT1 (PIAS1) mRNAs compared to complete responders before IQ treatment. We hypothesize that high-level expression of STAT1 and IRF1 is advantageous for a better IQ response. The observed differences in constitutive mRNA levels of these genes may be the consequence of alterations in cellular differentiation and\/or variable expression of endogenous interferons. Previous in vitro studies showed that keratinocyte differentiation coordinates the balance between positive and negative signals along the JAK\/STAT pathway by regulating the IRF1:IRF2 and STAT1:PIAS1 ratios and thus affecting induction of IQ-inducible genes. Specifically, differentiation supports constitutive expression of STAT1 and IRF1 mRNAs but not expression of IRF2 and PIAS1. Our data are in good agreement with studies that showed the importance of STAT1 in cytokine induction and activation of interferon-responsive genes by IQ.<\/jats:p>","DOI":"10.1128\/aac.44.7.1869-1873.2000","type":"journal-article","created":{"date-parts":[[2002,7,27]],"date-time":"2002-07-27T10:06:42Z","timestamp":1027764402000},"page":"1869-1873","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":26,"title":["Correlation between Pretreatment Levels of Interferon Response Genes and Clinical Responses to an Immune Response Modifier (Imiquimod) in Genital Warts"],"prefix":"10.1128","volume":"44","author":[{"given":"I.","family":"Arany","sequence":"first","affiliation":[{"name":"<!--label omitted: 1-->Departments of Microbiology and Immunology1 and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. K.","family":"Tyring","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->Departments of Microbiology and Immunology1 and"},{"name":"<!--label omitted: 2-->Dermatology,2 University of Texas Medical Branch, Galveston, Texas;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. M.","family":"Brysk","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->Departments of Microbiology and Immunology1 and"},{"name":"<!--label omitted: 2-->Dermatology,2 University of Texas Medical Branch, Galveston, Texas;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. A.","family":"Stanley","sequence":"additional","affiliation":[{"name":"<!--label omitted: 3-->Department of Pathology, University of Cambridge, Cambridge, United Kingdom3; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. A.","family":"Tomai","sequence":"additional","affiliation":[{"name":"<!--label omitted: 4-->3M Pharmaceuticals, St. Paul, Minnesota4"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. L.","family":"Miller","sequence":"additional","affiliation":[{"name":"<!--label omitted: 4-->3M Pharmaceuticals, St. Paul, Minnesota4"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. H.","family":"Smith","sequence":"additional","affiliation":[{"name":"<!--label omitted: 4-->3M Pharmaceuticals, St. Paul, Minnesota4"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. J.","family":"McDermott","sequence":"additional","affiliation":[{"name":"<!--label omitted: 4-->3M Pharmaceuticals, St. Paul, Minnesota4"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H. B.","family":"Slade","sequence":"additional","affiliation":[{"name":"<!--label omitted: 4-->3M Pharmaceuticals, St. Paul, Minnesota4"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_1_2_2","first-page":"118","article-title":"Imiquimod for genital warts.","volume":"39","author":"Anonymous","year":"1997","unstructured":"Anonymous Imiquimod for genital warts. Med. Lett. Drugs Ther. 39 1997 118 119","journal-title":"Med. Lett. Drugs Ther."},{"key":"e_1_3_1_3_2","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0166-3542(95)00970-1","article-title":"Response to interferon treatment decreases with epidermal dedifferentiation in condylomas.","volume":"32","author":"Arany I.","year":"1996","unstructured":"Arany I. Brysk M. M. Brysk H. Tyring S. K. Response to interferon treatment decreases with epidermal dedifferentiation in condylomas. Antivir. Res. 32 1996 19 26","journal-title":"Antivir. Res."},{"key":"e_1_3_1_4_2","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1089\/jir.1996.16.453","article-title":"Activation of local cell-mediated immunity in interferon responsive patients with human papillomavirus-associated lesions.","volume":"16","author":"Arany I.","year":"1996","unstructured":"Arany I. Tyring S. K. Activation of local cell-mediated immunity in interferon responsive patients with human papillomavirus-associated lesions. J. Interferon Cytokine Res. 16 1996 453 460","journal-title":"J. Interferon Cytokine Res."},{"key":"e_1_3_1_5_2","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1097\/00007435-199611000-00007","article-title":"Status of local cellular immunity in interferon responsive and nonresponsive human papillomavirus-associated lesions.","volume":"26","author":"Arany I.","year":"1996","unstructured":"Arany I. Tyring S. K. Status of local cellular immunity in interferon responsive and nonresponsive human papillomavirus-associated lesions. Sex. Transm. Dis. 26 1996 475 480","journal-title":"Sex. Transm. Dis."},{"key":"e_1_3_1_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(98)70243-9"},{"key":"e_1_3_1_7_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.43.4.856"},{"key":"e_1_3_1_8_2","first-page":"213","article-title":"Epithelial cell responsiveness to interferon gamma: epidermis vs. buccal mucosa.","volume":"3","author":"Brysk M. M.","year":"1995","unstructured":"Brysk M. M. Arany I. Brysk H. Chen S.-H. Calhoun K. H. Tyring S. K. Epithelial cell responsiveness to interferon gamma: epidermis vs. buccal mucosa. Mol. Cell. Differ. 3 1995 213 223","journal-title":"Mol. Cell. Differ."},{"key":"e_1_3_1_9_2","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/0003-9969(95)00046-R","article-title":"Gene expression of markers associated with proliferation and differentiation in keratinocytes cultured from skin and from oral mucosa.","volume":"40","author":"Brysk M. M.","year":"1995","unstructured":"Brysk M. M. Arany I. Brysk H. Chen S.-H. Calhoun K. H. Tyring S. K. Gene expression of markers associated with proliferation and differentiation in keratinocytes cultured from skin and from oral mucosa. Arch. Oral Biol. 40 1995 855 862","journal-title":"Arch. Oral Biol."},{"key":"e_1_3_1_10_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.277.5332.1630"},{"key":"e_1_3_1_11_2","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1001\/archderm.134.1.25","article-title":"Self-administered topical 5% imiquimod cream for external anogenital warts.","volume":"134","author":"Edwards L.","year":"1998","unstructured":"Edwards L. Ferenczy A. Eron L. Baker D. Owens M. L. Fox T. L. Hougham A. J. Schmitt K. A. Self-administered topical 5% imiquimod cream for external anogenital warts. Arch. Dermatol. 134 1998 25 30","journal-title":"Arch. Dermatol."},{"key":"e_1_3_1_12_2","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/BF02258360","article-title":"Activation of STAT transcription factors in oncogenic tyrosine kinase signaling.","volume":"5","author":"Garcia R.","year":"1998","unstructured":"Garcia R. Jove R. Activation of STAT transcription factors in oncogenic tyrosine kinase signaling. J. Biomed. Sci. 5 1998 79 85","journal-title":"J. Biomed. Sci."},{"key":"e_1_3_1_13_2","doi-asserted-by":"publisher","DOI":"10.1089\/jir.1995.15.537"},{"key":"e_1_3_1_14_2","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1159\/000150569","article-title":"Therapy of human papillomavirus infection and associated epithelial tumors.","volume":"40","author":"Gross G.","year":"1997","unstructured":"Gross G. Therapy of human papillomavirus infection and associated epithelial tumors. Intervirology 40 1997 368 377","journal-title":"Intervirology"},{"key":"e_1_3_1_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(89)90107-4"},{"key":"e_1_3_1_16_2","doi-asserted-by":"publisher","DOI":"10.1128\/mcb.14.2.1500-1509.1994"},{"key":"e_1_3_1_17_2","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S0300-9084(99)80017-0","article-title":"The role of interferon regulatory factors in the interferon system and cell growth.","volume":"80","author":"Harada H.","year":"1998","unstructured":"Harada H. Taniguchi T. Tanaka N. The role of interferon regulatory factors in the interferon system and cell growth. Biochimie 80 1998 641 650","journal-title":"Biochimie"},{"key":"e_1_3_1_18_2","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0092-8674(80)90406-7","article-title":"Calcium regulation of growth and differentiation of mouse epidermal cells in culture.","volume":"19","author":"Hennings H.","year":"1980","unstructured":"Hennings H. Michael D. Cheng C. Steinert P. Holbrook K. Yuspa S. H. Calcium regulation of growth and differentiation of mouse epidermal cells in culture. Cell 19 1980 245 254","journal-title":"Cell"},{"key":"e_1_3_1_19_2","doi-asserted-by":"crossref","first-page":"4260","DOI":"10.4049\/jimmunol.158.9.4260","article-title":"IFN regulatory factor-1 plays a central role in the regulation of the expression of class I and II MHC genes in vivo.","volume":"158","author":"Hobart M.","year":"1997","unstructured":"Hobart M. Ramassar V. Goes N. Urmson J. Halloran P. F. IFN regulatory factor-1 plays a central role in the regulation of the expression of class I and II MHC genes in vivo. J. Immunol. 158 1997 4260 4269","journal-title":"J. Immunol."},{"key":"e_1_3_1_20_2","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1038\/sj.leu.2400723","article-title":"Expression of interferon regulatory factor (IRF) genes and response to interferon-\u03b1 in chronic myeloid leukemia.","volume":"11","author":"Hochhaus A.","year":"1997","unstructured":"Hochhaus A. Yan X. Willer A. Hehlmann R. Gordon M. Y. Goldman J. M. Melo J. V. Expression of interferon regulatory factor (IRF) genes and response to interferon-\u03b1 in chronic myeloid leukemia. Leukemia 11 1997 933 939","journal-title":"Leukemia"},{"key":"e_1_3_1_21_2","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/S0959-437X(98)80015-4","article-title":"STAT structure and function in signaling.","volume":"8","author":"Hoey T.","year":"1998","unstructured":"Hoey T. Schindler U. STAT structure and function in signaling. Curr. Opin. Genet. Dev. 8 1998 582 587","journal-title":"Curr. Opin. Genet. Dev."},{"key":"e_1_3_1_22_2","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0955-0674(97)80067-1","article-title":"The state of the STATs: recent developments in the study of signal transduction to the nucleus.","volume":"9","author":"Horvath C. M.","year":"1997","unstructured":"Horvath C. M. Darnell J. E. The state of the STATs: recent developments in the study of signal transduction to the nucleus. Curr. Opin. Cell Biol. 9 1997 233 239","journal-title":"Curr. Opin. Cell Biol."},{"key":"e_1_3_1_23_2","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1084\/jem.189.1.63","article-title":"STAT3 is required for the gp130-mediated full activation of the c-myc genes.","volume":"189","author":"Kiuchi N.","year":"1999","unstructured":"Kiuchi N. Nakajima K. Ichiba M. Fukada T. Narimatsu M. Mizuno K. Hibi M. Hirano T. STAT3 is required for the gp130-mediated full activation of the c-myc genes. J. Exp. Med. 189 1999 63 73","journal-title":"J. Exp. Med."},{"key":"e_1_3_1_24_2","first-page":"71","article-title":"Effects of a novel topical immunomodulator, imiquimod, on keratinocyte cytokine gene expression.","volume":"13","author":"Kono T.","year":"1994","unstructured":"Kono T. Kondo S. Pastore S. Shivji G. M. Tomai M. A. McKenzie R. C. Sauder D. N. Effects of a novel topical immunomodulator, imiquimod, on keratinocyte cytokine gene expression. Lymphokine Cytokine Res. 13 1994 71 76","journal-title":"Lymphokine Cytokine Res."},{"key":"e_1_3_1_25_2","doi-asserted-by":"crossref","first-page":"3283","DOI":"10.1093\/nar\/23.16.3283","article-title":"STAT protein complexes activated by interferon-\u03b3 and gp130 signaling molecules differ in their sequence preferences and transcriptional induction properties.","volume":"23","author":"Lamb P.","year":"1995","unstructured":"Lamb P. Seidel H. M. Haslam J. Milocco L. Kessler L. V. Stein R. B. Rosen J. STAT protein complexes activated by interferon-\u03b3 and gp130 signaling molecules differ in their sequence preferences and transcriptional induction properties. Nucleic Acids Res. 23 1995 3283 3289","journal-title":"Nucleic Acids Res."},{"key":"e_1_3_1_26_2","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1096\/fasebj.10.14.9002549","article-title":"Regulation of STAT-dependent pathways by growth factors and cytokines.","volume":"10","author":"Leaman D. W.","year":"1996","unstructured":"Leaman D. W. Leung S. Li X. Stark G. R. Regulation of STAT-dependent pathways by growth factors and cytokines. FASEB J. 10 1996 1578 1588","journal-title":"FASEB J."},{"key":"e_1_3_1_27_2","doi-asserted-by":"crossref","first-page":"10626","DOI":"10.1073\/pnas.95.18.10626","article-title":"Inhibition of Stat1-mediated gene activation by PIAS1.","volume":"95","author":"Liu B.","year":"1998","unstructured":"Liu B. Liao J. Rao X. Kushner S. A. Chung C. D. Chang D. D. Inhibition of Stat1-mediated gene activation by PIAS1. Proc. Natl. Acad. Sci. USA 95 1998 10626 10631","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"e_1_3_1_28_2","doi-asserted-by":"crossref","first-page":"100S","DOI":"10.1111\/1523-1747.ep12874944","article-title":"Evidence for an epidermal cytokine network.","volume":"95","author":"Luger T. A.","year":"1990","unstructured":"Luger T. A. Schwarz T. Evidence for an epidermal cytokine network. J. Investig. Dermatol. 95 1990 100S 104S","journal-title":"J. Investig. Dermatol."},{"key":"e_1_3_1_29_2","doi-asserted-by":"crossref","first-page":"42S","DOI":"10.1111\/1523-1747.ep12668619","article-title":"Cytokine expression by epidermal cell subpopulations.","volume":"99","author":"Matsue H.","year":"1992","unstructured":"Matsue H. Cruz P. D. Jr. Bergstresser P. R. Takashima A. Cytokine expression by epidermal cell subpopulations. J. Investig. Dermatol. 99 1992 42S 45S","journal-title":"J. Investig. Dermatol."},{"key":"e_1_3_1_30_2","doi-asserted-by":"crossref","first-page":"99S","DOI":"10.1038\/jid.1995.20","article-title":"Skin associated lymphoid tissue in HIV-1, HPV and HSV infections.","volume":"105","author":"Memar O.","year":"1995","unstructured":"Memar O. Arany I. Tyring S. K. Skin associated lymphoid tissue in HIV-1, HPV and HSV infections. J. Investig. Dermatol. 105 1995 99S 104S","journal-title":"J. Investig. Dermatol."},{"key":"e_1_3_1_31_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0192-0561(98)00068-X","article-title":"Imiquimod applied topically: a novel immune response modifier and new class of drug.","volume":"21","author":"Miller R. L.","year":"1999","unstructured":"Miller R. L. Gerster J. F. Owens M. L. Slade H. B. Tomai M. A. Imiquimod applied topically: a novel immune response modifier and new class of drug. Int. J. Immunopharmacol. 21 1999 1 14","journal-title":"Int. J. Immunopharmacol."},{"key":"e_1_3_1_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1359-6101(97)00019-1"},{"key":"e_1_3_1_33_2","doi-asserted-by":"crossref","first-page":"4134","DOI":"10.1074\/jbc.271.8.4134","article-title":"Preassociation of STAT1 with STAT2 and STAT3 in separate signalling complexes prior to cytokine stimulation.","volume":"271","author":"Stancato L. F.","year":"1996","unstructured":"Stancato L. F. David M. Carter-Su C. Larner A. C. Pratt W. B. Preassociation of STAT1 with STAT2 and STAT3 in separate signalling complexes prior to cytokine stimulation. J. Biol. Chem. 271 1996 4134 4137","journal-title":"J. Biol. Chem."},{"key":"e_1_3_1_34_2","first-page":"23","article-title":"Mechanism of action of imiquimod.","volume":"10","author":"Stanley M. A.","year":"1999","unstructured":"Stanley M. A. Mechanism of action of imiquimod. Papillomavirus Rep. 10 1999 23 29","journal-title":"Papillomavirus Rep."},{"key":"e_1_3_1_35_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.biochem.67.1.227"},{"key":"e_1_3_1_36_2","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/(SICI)1521-1878(199901)21:1<47::AID-BIES6>3.0.CO;2-N","article-title":"Negative regulation of the JAK\/STAT pathway.","volume":"21","author":"Starr R.","year":"1999","unstructured":"Starr R. Hilton D. J. Negative regulation of the JAK\/STAT pathway. Bioessays 21 1999 47 52","journal-title":"Bioessays"},{"key":"e_1_3_1_37_2","first-page":"43","article-title":"Regulation of the interferon system, immune response and oncogenesis by the transcription factor interferon regulatory factor-1.","volume":"9","author":"Taniguchi T.","year":"1998","unstructured":"Taniguchi T. Tanaka N. Taki S. Regulation of the interferon system, immune response and oncogenesis by the transcription factor interferon regulatory factor-1. Eur. Cytokine Netw. 9 1998 43 48","journal-title":"Eur. Cytokine Netw."},{"key":"e_1_3_1_38_2","doi-asserted-by":"publisher","DOI":"10.1002\/jlb.58.3.365"},{"key":"e_1_3_1_39_2","doi-asserted-by":"publisher","DOI":"10.1086\/517472"},{"key":"e_1_3_1_40_2","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/0014-5793(96)00990-8","article-title":"IL-10 induces DNA binding activity of three STAT proteins (Stat1, Stat3, and Stat5) and their distinct combinatorial assembly in the promoters of selected genes.","volume":"394","author":"Wehinger J.","year":"1996","unstructured":"Wehinger J. Gouilleux F. Groner B. Finke J. Mertelsmann R. Weber-Nordt R. M. IL-10 induces DNA binding activity of three STAT proteins (Stat1, Stat3, and Stat5) and their distinct combinatorial assembly in the promoters of selected genes. FEBS Lett. 394 1996 365 370","journal-title":"FEBS Lett."}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.44.7.1869-1873.2000","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.44.7.1869-1873.2000","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,23]],"date-time":"2023-04-23T15:51:12Z","timestamp":1682265072000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.44.7.1869-1873.2000"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,7]]},"references-count":39,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2000,7]]}},"alternative-id":["10.1128\/AAC.44.7.1869-1873.2000"],"URL":"https:\/\/doi.org\/10.1128\/aac.44.7.1869-1873.2000","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,7]]},"assertion":[{"value":"1999-12-13","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2000-04-25","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2000-07-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}